<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04859400</url>
  </required_header>
  <id_info>
    <org_study_id>2020-02992</org_study_id>
    <nct_id>NCT04859400</nct_id>
  </id_info>
  <brief_title>Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients</brief_title>
  <official_title>Influence of a Home-based Nutrition and Exercise Program Including an Application for Monitoring on Quality of Life in Palliative Cancer Outpatients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Winterthur KSW</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Krebsforschung Schweiz, Bern, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sponser Sport Food AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leitwert GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SNAQ AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kantonsspital St. Gallen CTU</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kantonsspital Winterthur KSW</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of the study is to investigate whether a tailor-made nutritional and&#xD;
      exercise program including home-based sessions and regular monitoring using an application on&#xD;
      the smartphone is effective in improving Quality of Life in patients with advanced lung or&#xD;
      gastrointestinal tract cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cachexia is highly prevalent among cancer patients and has substantial impact on the Quality&#xD;
      of Life (QoL) and the functional status of patients.Therefore, the main purpose of this study&#xD;
      is to investigate whether a mainly home-based nutritional and exercise program including&#xD;
      regular monitoring using an application on the smartphone is effective in improving QoL in&#xD;
      patients with advanced lung or gastrointestinal tract cancer.&#xD;
&#xD;
      The study desing is a randomized, two-arm and multicenter international trial and advanced&#xD;
      lung or gastrointestinal cancer patients not eligible for curative treatment make up the&#xD;
      patient population.&#xD;
&#xD;
      Patients in the intervention group receive a nutrition and exercise program in combination&#xD;
      with an electronic application for data collection and monitoring.&#xD;
&#xD;
      The nutritional program comprises an extensive nutritional assessment and an individual&#xD;
      nutritional recommendation. In addition, patients receive a whey protein supplement high in&#xD;
      leucine and β-hydroxy-β-methylbutyrate (HMB) to support an optimal protein intake in&#xD;
      combination with physical activity. The nutritional situation is reassessed at 2 -3 weeks.&#xD;
&#xD;
      Exercise counselling includes at least two visits with an extensive first baseline&#xD;
      assessment. On this basis, an individual training program for 12 weeks in a home-based&#xD;
      setting is compiled, with mainly strength and endurance exercises. At week 2-3, the patient&#xD;
      and the study physiotherapist have a follow-up meeting.&#xD;
&#xD;
      The application Swiss NutriAct is mainly used for data collection (nutritional, exercise and&#xD;
      QoL data). Since the study coordinator, dietician and physiotherapist can see the information&#xD;
      entered by the intervention group patients, they can contact patients and offer help&#xD;
      regarding the nutrition and exercise program, where deemed appropriate. Vice versa, patients&#xD;
      can use the help button to contact the study team to ask questions regarding the nutrition&#xD;
      and exercise program.&#xD;
&#xD;
      Patients in the control group receive standard of care and a limited version of the&#xD;
      application.&#xD;
&#xD;
      Both arms will be assessed at baseline (0 weeks), after the 12 weeks intervention phase and&#xD;
      at a follow up assessment after 24 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 7, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>QoL</measure>
    <time_frame>3 Months</time_frame>
    <description>Questionnaire Functional Assessment of Cancer Therapy - General (FACT-G)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>3 months</time_frame>
    <description>Body weight (in kg), used in combination with body height to calculate BMI (in kg/m2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>3 months</time_frame>
    <description>Patient-generated subjective global assessment (PGSGA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>3 months</time_frame>
    <description>Bioelectrical impedance analysis (BIA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>3 months</time_frame>
    <description>Muscle mass: L3 image of computertomographic (CT) measurements taken in the context of standard cancer therapy (divided by height squared; in cm2/m2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>3 months</time_frame>
    <description>Calf circumference (in cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>3 months</time_frame>
    <description>Sarcopenia screening questionnaire SARC-F</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function</measure>
    <time_frame>3 months</time_frame>
    <description>Handgrip strength (in kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function</measure>
    <time_frame>3 months</time_frame>
    <description>60 s sit-to-stand test (number of stands)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function</measure>
    <time_frame>3 months</time_frame>
    <description>6 minute walk test (in m)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy- and protein intake</measure>
    <time_frame>3 months</time_frame>
    <description>Data collected with application, Harris-Benedict formula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>3 months</time_frame>
    <description>Questionnaire Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical data</measure>
    <time_frame>3 months</time_frame>
    <description>Physical performance status (WHO performance status, grade 0-5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical data</measure>
    <time_frame>3 months</time_frame>
    <description>Tumor stadium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical data</measure>
    <time_frame>3 months</time_frame>
    <description>Adverse events grade 3 and 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical data</measure>
    <time_frame>3 months</time_frame>
    <description>Serious adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical data</measure>
    <time_frame>3 months</time_frame>
    <description>Unplanned hospital readmissions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical data</measure>
    <time_frame>3 months</time_frame>
    <description>Survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to the nutritional and exercise program</measure>
    <time_frame>3 months</time_frame>
    <description>According to data collected with application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability of the new application</measure>
    <time_frame>3 months</time_frame>
    <description>Questionnaire mHealth App Usability (MAUQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success of recruitment rate in comparison to former studies</measure>
    <time_frame>Through study completion (24 months)</time_frame>
    <description>Number of eligible patients, participants, rejections as compared to similar past studies</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Cancer, Gastrointestinal</condition>
  <condition>Cancer, Lung</condition>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>standardized nutritional program including a nutritional supplement&#xD;
standardized exercise program&#xD;
app for monitoring.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard of care&#xD;
limited version of the app (e.g. without the &quot;help&quot; function).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein supplement high in leucine and β-hydroxy-β-methylbutyrate (HMB)</intervention_name>
    <description>The whey protein supplement high in leucine and β-hydroxy-β-methylbutyrate (HMB) is ingested once daily, preferably either in the evening before going to bed or within two hours after having finished exercising.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standardized nutritional program</intervention_name>
    <description>During at least two personal counseling meetings with a dietician, the patient's diet is assessed and individual nutritional interventions - based on the personal needs and individual preferences of the patient - are developed. The overall goal is to optimize protein an energy intake.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standardized exercise program</intervention_name>
    <description>In at least two personal counseling meetings with a physiotherapist, the patient's individual training plan is compiled and agreed upon (mainly including strength, endurance and balance exercises). The patient then exercises at home and records the trainings with the app.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Advanced lung or gastrointestinal cancer patients not eligible for curative treatment&#xD;
&#xD;
          -  WHO performance status of ≤ 2&#xD;
&#xD;
          -  Able to perform physical exercise estimated by the treating physician&#xD;
&#xD;
          -  Estimated life expectancy of ≥ 6 months&#xD;
&#xD;
          -  Patient must give written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intake of supplements with high-dose branched-chain amino acids within one month&#xD;
&#xD;
          -  Enteral (except oral nutritional supplements) and/or parenteral nutrition within one&#xD;
             month&#xD;
&#xD;
          -  History of ileus within previous month&#xD;
&#xD;
          -  Milk protein allergy&#xD;
&#xD;
          -  The patient cannot understand the trial-specific content due to linguistic,&#xD;
             psychological or disease reasons&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miklos Pless, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Winterthur KSW</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucia Gafner, Dr. sc. nat.</last_name>
    <phone>+41 52 266 21 37</phone>
    <email>lucia.gafner@ksw.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lena Storck, Dr. rer. med.</last_name>
    <phone>+41 52 266 23 27</phone>
    <email>lena.storck@ksw.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Winterthur</name>
      <address>
        <city>Winterthur</city>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucia Gafner, Dr. sc. nat.</last_name>
      <phone>+41 52 266 21 37</phone>
      <email>lucia.gafner@ksw.ch</email>
    </contact>
    <contact_backup>
      <last_name>Lena J. Storck, Dr. (rer.) med.</last_name>
      <phone>+41 52 266 23 27</phone>
      <email>lena.storck@ksw.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Miklos Pless, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 8, 2021</study_first_submitted>
  <study_first_submitted_qc>April 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer</keyword>
  <keyword>Palliative</keyword>
  <keyword>Application</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share individual participant data (IPD) with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

